{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:44:38Z","timestamp":1776401078476,"version":"3.51.2"},"reference-count":72,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2024,5,27]]},"DOI":"10.1080\/14737167.2024.2348053","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T07:24:20Z","timestamp":1714116260000},"page":"589-597","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Cost effectiveness of hepatitis C direct acting agents"],"prefix":"10.1080","volume":"24","author":[{"given":"Akshay","family":"Shetty","sequence":"first","affiliation":[{"name":"University of California at Los Angeles","place":["Los Angeles, USA"]},{"name":"University of California at Los Angeles","place":["Los Angeles, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Lee","sequence":"additional","affiliation":[{"name":"University of California at Los Angeles","place":["Los Angeles, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Valenzuela","sequence":"additional","affiliation":[{"name":"University of California at Los Angeles","place":["Los Angeles, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sammy","family":"Saab","sequence":"additional","affiliation":[{"name":"University of California at Los Angeles","place":["Los Angeles, USA"]},{"name":"University of California at Los Angeles","place":["Los Angeles, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,5,3]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00608-8"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0406"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1810477"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.03.004"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27736"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25842"},{"key":"e_1_3_4_9_1","unstructured":"2020 viral hepatitis surveillance report. Centers for Disease Control and Prevention. 2022 Aug 18 [cited 2023 Oct 24]. Available from: https:\/\/www.cdc.gov\/hepatitis\/statistics\/2020surveillance\/index.htm"},{"key":"e_1_3_4_10_1","doi-asserted-by":"crossref","unstructured":"Ryerson AB Vital signs: newly reported acute and chronic hepatitis C cases \u2015 United States 2009\u20132018. Centers for Disease Control and Prevention. 2023 Mar 17 [cited 2023 Oct 24]. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/69\/wr\/mm6914a2.htm#suggestedcitation","DOI":"10.15585\/mmwr.mm6914a2"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29685"},{"key":"e_1_3_4_12_1","unstructured":"Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. World Health Organization. 2018 Jul 1 [cited 2023 Oct 24]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241550345"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00386-7"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.11.045"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1596\/978-0-8213-6260-0\/Chpt-3"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540150055031"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-018-0410-x"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14301"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221769"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13419"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01166-3"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2019.1629291"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-020-00623-3"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-058757"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.10.006"},{"key":"e_1_3_4_26_1","volume-title":"Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and diagnostics","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and diagnostics. Geneva: WHO; 2022 [cited 2024 Jan 1].https:\/\/www.who.int\/publications\/i\/item\/9789240052734"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.09.067"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2017.01.033"},{"key":"e_1_3_4_29_1","unstructured":"US Centers for Disease Control and Prevention. Surveillance Data for Viral Hepatitis. 2021 [cited 2024 Jan 4]. Available from: https:\/\/www.cdc.gov\/hepatitis\/statistics\/2021surveillance\/hepatitis-c.htm"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27978"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00472-6"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.15756"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.08.080"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz383"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045176"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4524-z"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.05.027"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i11.1327"},{"key":"e_1_3_4_39_1","unstructured":"Global progress report on HIV viral hepatitis and sexually transmitted infections. World Health Organization. 2021 Jul 15 [cited 2023 Oct 24]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240027077"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2023.06.016"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw211"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30505-2"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.7085"},{"key":"e_1_3_4_44_1","unstructured":"Knox R $1 000 pill for hepatitis C spurs debate over drug prices. Npr. 2013 Dec 30 [cited 2023 Oct 24]. Available from: https:\/\/www.npr.org\/sections\/health-shots\/2013\/12\/30\/256885858\/-1-000-pill-for-hepatitis-c-spurs-debate-over-drug-prices."},{"issue":"6","key":"e_1_3_4_45_1","first-page":"SP220","article-title":"Coverage for hepatitis C drugs in medicare part D","volume":"22","author":"Jung JK","year":"2016","unstructured":"Jung JK, Feldman R, Cheong C, et al. Coverage for hepatitis C drugs in medicare part D. Am J Manag Care. 2016;22(6 Spec No.):SP220\u2013SP226.","journal-title":"Am J Manag Care"},{"key":"e_1_3_4_46_1","unstructured":"Ornstein C. The cost of a cure: medicare spent $4.5 billion on new hepatitis C drugs last year. ProPublica. 2015 Mar 30 [cited 2023 Oct 24]. Available from: https:\/\/www.propublica.org\/article\/cost-of-a-cure-medicare-spent-4.5-billion-on-hepatitis-c-drugs-last-year"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.5367"},{"key":"e_1_3_4_48_1","unstructured":"Tice TJ Ollendorf DA Chahal HS et al. The comparative clinical effectiveness and value of novel combination therapies for the treatment of patients with genotype 1 chronic hepatitis C infection. Institute for Clinical and Economic Review. 2015 Jan 30 [cited 2023 Oct 24]. Available from: https:\/\/icer.org\/wp-conent\/uploads\/2020\/10\/Response_to_Public_Coments_013015.pdf"},{"key":"e_1_3_4_49_1","unstructured":"American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. HCV guidance: recommendations for testing managing and treating hepatitis C. 2019 [cited 2023 Oct 23]. Available from: https:\/\/www.hcvguidelines.org\/contents"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.26.7.879"},{"issue":"4","key":"e_1_3_4_51_1","first-page":"260","article-title":"Pr\u00e9sentation d\u2019une grille d\u2019analyse informatis\u00e9e pour le recueil des l\u00e9sions histopathologiques dans l\u2019h\u00e9patite chronique virale C. Etude coop\u00e9rative du groupe METAVIR [Presentation of a grid for computer analysis for compilation of histopathologic lesions in chronic viral hepatitis C. Cooperative study of the METAVIR group]","volume":"13","author":"Bedossa P","year":"1993","unstructured":"Bedossa P. Pr\u00e9sentation d\u2019une grille d\u2019analyse informatis\u00e9e pour le recueil des l\u00e9sions histopathologiques dans l\u2019h\u00e9patite chronique virale C. Etude coop\u00e9rative du groupe METAVIR [Presentation of a grid for computer analysis for compilation of histopathologic lesions in chronic viral hepatitis C. Cooperative study of the METAVIR group]. Ann Pathol. 1993;13(4):260\u2013265.","journal-title":"Ann Pathol"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13223"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163488"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-311504"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14731"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz726"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15456"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.16305"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003653"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28497"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52564-0"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.18176\/resp.00012"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245896"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad637"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13383"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.08.042"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.06.024"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12877"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000524"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32341"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03272-1"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13878"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109878"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-023-00389-8"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2024.2348053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T09:51:32Z","timestamp":1739181092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2024.2348053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,27]]}},"alternative-id":["10.1080\/14737167.2024.2348053"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2024.2348053","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}